![](https://pmlive.com/wp-content/uploads/2024/02/NEW_AstraZeneca_shutterstock_1820522576-640.jpg)
AstraZeneca’s Tagrisso combination approved by EC as first-line lung cancer treatment
AstraZeneca’s (AZ) Tagrisso (osimertinib) has been approved by the European Commission (EC) as part of a combination treatment for a subset of advanced lung cancer patients. The epidermal growth factor receptor-mutated (EGFR)-tyrosine kinase inhibitor has …